Kyle Diamond, MD
Vascular Surgery · Stuart, FLNPI 1669834636
Payments from drug & device makers
Across 185 payments — averaging $72.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Penumbra, Inc.$2K
- W. L. Gore & Associates, Inc.$2K
- BD$1K
- Bolton Medical Inc$1K
- Philips North America LLC$927
- plus $4K from 23 others
What the payments were for
- Consulting fees$1,57012%
- Travel & lodging$2,66420%
- Food & beverage$8,55263%
- Education$6935%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 15 | $2,105 |
| Penumbra, Inc. | 5 | $1,908 |
| W. L. Gore & Associates, Inc. | 33 | $1,769 |
| BD | 4 | $1,331 |
| Bolton Medical Inc | 8 | $1,152 |
| Philips North America LLC | 26 | $927 |
| Terumo Medical Corporation | 8 | $885 |
| Endologix LLC | 6 | $626 |
| Cook Medical LLC | 10 | $528 |
| Inari Medical, Inc. | 5 | $422 |
| Shockwave Medical, Inc | 2 | $332 |
| Boston Scientific | 11 | $309 |
| Silk Road Medical, Inc. | 6 | $256 |
| Johnson & Johnson | 12 | $208 |
| Tactile Systems Technology Inc | 6 | $141 |
| Abbott | 3 | $117 |
| Surmodics, Inc. | 4 | $95 |
| Angiodynamics, Inc. | 3 | $69 |
| Organogenesis Inc. | 2 | $54 |
| Lemaitre Vascular, Inc. | 2 | $37 |
| Kerecis Limited | 1 | $36 |
| Smith+Nephew | 2 | $31 |
| Cardiovascular Systems Inc. | 1 | $30 |
| Cardiva Medical, Inc. | 1 | $25 |
| Sirtex Medical Inc | 4 | $19 |
| Inspiremd Ltd | 1 | $18 |
| Reflow Medical Inc | 2 | $17 |
| Mozarc Medical US LLC | 1 | $17 |
| Bard Peripheral Vascular, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,787
- Azur CX Detachable$711
- ELLIPSYS VASCULAR ACCESS SYSTEM$581
- Grafts$430
- TREO ABDOMINAL STENT-GRAFT SYSTEM$423
- Alto Abdominal Stent Graft System$373
- FLOWTRIEVER CATHETER, S$343
- CT THROMBECTOMY SYSTEM KIT$343
- GORE VIABAHN VBX Balloon Expandable Endo$342
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$332
- ClosureRFG$297
- GORE TAG Conformable Thoracic Endoprosthesis$279
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$260
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$193
- ENDURANT IIS$169
- HawkOne$161
- GENERAL VASCULAR INTERVENTION$144
- Zenith Spiral-Z$130
- Zenith$129
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$126
How this compares
$13,478 in reported general payments places this provider in the 65th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 130 | $118,423 |
| ClopidogrelClopidogrel Bisulfate | 79 | $967 |
| Atorvastatin Calcium | 50 | $667 |
| Ketorolac Tromethamine | 19 | $241 |
| Methylprednisolone | 13 | $94 |
| Cephalexin | 37 | $79 |
| Diazepam | 24 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $208 | $118,423130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Stuart
- Samuel TapperStuart$1.3M
- Erin MooreJacksonville$488K
- Mariano ArosemenaBradenton$472K
- Woongchae LeeBoca Raton$414K
- Manuel Perez IzquierdoOrlando$396K
- Murray ShamesTampa$354K
- Joseph RicottaDelray Beach$344K
- Martin BackTampa$303K
- Rajesh MalikNaples$296K
- Eduardo MartinezMiami$288K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.